(CFLT) Confluent - Ratings and Ratios
Cloud, Platform, Connectors, Flink, Warpstream, Governance
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 74.0% |
| Value at Risk 5%th | 85.9% |
| Relative Tail Risk | -29.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.36 |
| Alpha | -21.60 |
| CAGR/Max DD | 0.23 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.510 |
| Beta | 1.561 |
| Beta Downside | 1.820 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.49% |
| Mean DD | 30.18% |
| Median DD | 29.59% |
Description: CFLT Confluent January 07, 2026
Confluent, Inc. (NASDAQ:CFLT) delivers a cloud-native data-streaming platform that enables enterprises to build real-time applications across on-premises and public-cloud environments. Its product suite includes Confluent Cloud (a managed SaaS), Confluent Platform (self-managed), a library of pre-built connectors, Apache Flink-based stream processing, WarpStream (a BYOC managed service), and a governance layer that enforces risk- and compliance-related controls on streaming data.
The company monetizes through subscription fees (annual recurring revenue, ARR) and professional services. In FY 2024 Confluent reported ARR of roughly $1.2 billion, representing a 45 % YoY growth rate, while its net dollar retention exceeded 130 %, indicating strong upsell and cross-sell momentum among existing customers.
Confluent’s addressable market is driven by the broader shift toward event-driven architectures and the rise of real-time analytics in sectors such as banking, e-commerce, and telecom. Industry analysts estimate the global streaming data market to expand at a CAGR of 30 % through 2030, providing a secular tailwind for the company.
Key competitive pressures stem from large cloud providers (AWS Kinesis, Azure Event Hubs, Google Pub/Sub) and open-source alternatives, making customer acquisition cost (CAC) and product differentiation critical levers for sustainable growth.
Given the high growth trajectory and the strategic importance of real-time data pipelines, investors should monitor metrics such as churn, CAC payback period, and the pace of adoption of Confluent’s governance module. For a deeper dive into Confluent’s valuation metrics, see the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-304.1m TTM) > 0 and > 6% of Revenue (6% = 66.8m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 1.81pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 168.6% (prev 189.1%; Δ -20.53pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 57.4m > Net Income -304.1m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 4.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (346.2m) change vs 12m ago 6.75% (target <= -2.0% for YES) |
| Gross Margin 74.14% (prev 73.03%; Δ 1.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.59% (prev 35.11%; Δ 5.48pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -368.4 (EBITDA TTM -340.3m / Interest Expense TTM 1.00m) >= 6 (WARN >= 3) |
Altman Z'' -0.44
| (A) 0.65 = (Total Current Assets 2.50b - Total Current Liabilities 622.6m) / Total Assets 2.88b |
| (B) -0.77 = Retained Earnings (Balance) -2.21b / Total Assets 2.88b |
| (C) -0.13 = EBIT TTM -368.4m / Avg Total Assets 2.74b |
| (D) -1.25 = Book Value of Equity -2.20b / Total Liabilities 1.76b |
| Total Rating: -0.44 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 42.91
| 1. Piotroski 2.0pt |
| 2. FCF Yield 0.39% |
| 3. FCF Margin 3.41% |
| 4. Debt/Equity 0.99 |
| 5. Debt/Ebitda -2.37 |
| 6. ROIC - WACC (= -28.33)% |
| 7. RoE -29.17% |
| 8. Rev. Trend 98.92% |
| 9. EPS Trend 58.28% |
What is the price of CFLT shares?
Over the past week, the price has changed by +0.17%, over one month by +1.04%, over three months by +41.96% and over the past year by +1.17%.
Is CFLT a buy, sell or hold?
- Strong Buy: 20
- Buy: 8
- Hold: 7
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CFLT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.9 | 2.4% |
| Analysts Target Price | 30.9 | 2.4% |
| ValueRay Target Price | 31.9 | 5.7% |
CFLT Fundamental Data Overview January 01, 2026
P/E Forward = 61.7284
P/S = 9.5589
P/B = 9.5093
P/EG = 2.1225
Beta = 0.986
Revenue TTM = 1.11b USD
EBIT TTM = -368.4m USD
EBITDA TTM = -340.3m USD
Long Term Debt = 1.10b USD (from longTermDebt, last quarter)
Short Term Debt = 9.39m USD (from shortTermDebt, last quarter)
Debt = 1.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 807.9m USD (from netDebt column, last quarter)
Enterprise Value = 9.76b USD (10.64b + Debt 1.11b - CCE 1.99b)
Interest Coverage Ratio = -368.4 (Ebit TTM -368.4m / Interest Expense TTM 1.00m)
FCF Yield = 0.39% (FCF TTM 37.9m / Enterprise Value 9.76b)
FCF Margin = 3.41% (FCF TTM 37.9m / Revenue TTM 1.11b)
Net Margin = -27.32% (Net Income TTM -304.1m / Revenue TTM 1.11b)
Gross Margin = 74.14% ((Revenue TTM 1.11b - Cost of Revenue TTM 287.8m) / Revenue TTM)
Gross Margin QoQ = 74.22% (prev 73.73%)
Tobins Q-Ratio = 3.39 (Enterprise Value 9.76b / Total Assets 2.88b)
Interest Expense / Debt = 0.09% (Interest Expense 1.00m / Debt 1.11b)
Taxrate = -2.39% (negative due to tax credits) (1.55m / -65.0m)
NOPAT = -377.2m (EBIT -368.4m * (1 - -2.39%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 4.01 (Total Current Assets 2.50b / Total Current Liabilities 622.6m)
Debt / Equity = 0.99 (Debt 1.11b / totalStockholderEquity, last quarter 1.12b)
Debt / EBITDA = -2.37 (negative EBITDA) (Net Debt 807.9m / EBITDA -340.3m)
Debt / FCF = 21.31 (Net Debt 807.9m / FCF TTM 37.9m)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = -10.57% (Net Income -304.1m / Total Assets 2.88b)
RoE = -29.17% (Net Income TTM -304.1m / Total Stockholder Equity 1.04b)
RoCE = -17.23% (EBIT -368.4m / Capital Employed (Equity 1.04b + L.T.Debt 1.10b))
RoIC = -17.66% (negative operating profit) (NOPAT -377.2m / Invested Capital 2.14b)
WACC = 10.67% (E(10.64b)/V(11.75b) * Re(11.77%) + D(1.11b)/V(11.75b) * Rd(0.09%) * (1-Tc(-0.02)))
Discount Rate = 11.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.83%
[DCF Debug] Terminal Value 55.71% ; FCFE base≈37.9m ; Y1≈24.9m ; Y5≈11.4m
Fair Price DCF = 0.45 (DCF Value 137.6m / Shares Outstanding 303.2m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 58.28 | EPS CAGR: 0.0% | SUE: 0.66 | # QB: 0
Revenue Correlation: 98.92 | Revenue CAGR: 27.53% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.10 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=27
EPS next Year (2026-12-31): EPS=0.48 | Chg30d=-0.000 | Revisions Net=+18 | Growth EPS=+20.7% | Growth Revenue=+16.6%
Additional Sources for CFLT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle